健康设备

Search documents
上海再现排队热,39万高压氧舱走红富豪圈,他们表示:“只为留住年轻”
Sou Hu Cai Jing· 2025-07-05 04:25
Core Insights - The article highlights the growing popularity of high-pressure oxygen chambers, particularly from the company "Rlab," among high-net-worth individuals in major cities like Beijing, Shanghai, Guangzhou, and Shenzhen, indicating a shift in health management and lifestyle choices [1][5][9] Group 1: Market Performance - Rlab's sales revenue in the first quarter of this year reached a new high, with a year-on-year growth of 273.21%, and high-pressure oxygen chambers accounted for 83% of sales [1] - The high-pressure oxygen chamber, priced at 390,000 yuan per unit, is becoming a status symbol among affluent families, akin to luxury brands [1][5] Group 2: Consumer Behavior - High-net-worth individuals are increasingly willing to invest in scientifically-backed health management solutions, viewing high-pressure oxygen chambers as a proactive measure against health risks [5][9] - The concept of "ceremony" plays a significant role in attracting consumers, with luxurious features like a starry sky ceiling and home theater systems enhancing the experience [2][4] Group 3: Product Features and Customization - Rlab's oxygen chambers offer extensive customization options, from materials to lighting, catering to the unique aesthetic preferences of high-net-worth users [4] - The chambers are built with advanced materials and technology, including EU CE certification and endorsements from Israeli authorities, emphasizing their medical and engineering foundations [5][7] Group 4: Industry Perspectives - There is ongoing debate in the market regarding the efficacy of anti-aging technologies, with some experts questioning whether they provide real value or are merely a luxury tax [7][9] - Rlab's focus on engineering quality, personalized service, and comprehensive health management solutions positions its products as long-term health investments rather than mere consumer goods [8][9]
融捷健康:2024年报净利润0.47亿 同比增长74.07%
Tong Hua Shun Cai Bao· 2025-04-22 09:45
一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益(元) | 0.0600 | 0.0300 | 100 | 0.1600 | | 每股净资产(元) | 1.33 | 1.26 | 5.56 | 1.23 | | 每股公积金(元) | 1.67 | 1.67 | 0 | 1.67 | | 每股未分配利润(元) | -1.43 | -1.49 | 4.03 | -1.53 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 6.89 | 5.29 | 30.25 | 4.63 | | 净利润(亿元) | 0.47 | 0.27 | 74.07 | 1.26 | | 净资产收益率(%) | 4.50 | 2.65 | 69.81 | 14.12 | 数据四舍五入,查看更多财务数据>> 不分配不转增 前十大流通股东累计持有: 21756.62万股,累计占流通股比: 27.08%,较上期变化: -527.70万股。 ...